(MedPage Today) — MONTREAL — Patients with diabetic macular edema (DME) maintained improvements in visual acuity and retinal anatomy for up to 4 years with the ranibizumab port delivery system (PDS; Susvimo), according to updated results from…
Source link
Ad Banner
Show Comments (0)
Hide Comments (0)
Subscribe
Login
0 Comments
Oldest
